On this page you find listing prospectus since the IPO in 2019.
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. […]
Ascelia’s employees are passionate and driven to develop products that will help people with rare cancer conditions live longer and healthier lives. Jeanette Nilsson Clinical operations manager “- As the […]